Home Federal Bank Of Tennessee Provectus Biopharmaceuticals, Inc. Transaction History
Home Federal Bank Of Tennessee
- $328 Million
- Q2 2024
A detailed history of Home Federal Bank Of Tennessee transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Home Federal Bank Of Tennessee holds 100,000 shares of PVCT stock, worth $11,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$11,000
Previous $18,000
27.78%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
229KCall Options Held
0Put Options Held
0-
Lee Danner & Bass Inc50KShares$5,5000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$2,9280.0% of portfolio
-
Lbmc Investment Advisors, LLC22KShares$2,4200.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$2,2000.0% of portfolio
-
Financial Symmetry Inc Raleigh, NC10.2KShares$1,1210.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $46.1M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...